Members |
targetComponentId |
Contusion,trunk NOS |
Contusion of trunk |
ConvaTec two-piece ostomy system E |
Two-piece ostomy system |
Convalescence NOS |
Convalescence |
Convalescence NOS |
Convalescence |
Conventional release chewable capsule |
Conventional release chewable soft capsule (dose form) |
Conventional release intraocular solution |
Solution for injection |
Conventional release intravesical or parenteral or urethral solution |
Powder for conventional release intravesical solution and solution for injection (dose form) |
Conventional release pressurized suspension for nebulizer |
Conventional release suspension for nebulizer (dose form) |
Conventional release solution for intraocular injection |
Solution for injection |
Conventional release suspension for infusion |
Dispersion for infusion |
Conventional release vapor capsule for inhalation |
Capsule for vapor inhalation |
Conventional release vapor ointment for inhalation |
Ointment for vapour inhalation |
Conventional release vapor powder for inhalation |
Conventional release powder for vapor inhalation (dose form) |
Conventional release vapor solution for inhalation |
Solution for vapour inhalation |
Conventional release vapor tablet for inhalation |
Tablet for vapour inhalation |
Conversion from hemiarthroplasty of shoulder NEC |
Conversion from hemiarthroplasty of shoulder |
Conversion from hybrid total knee replacement NEC |
Conversion from hybrid total knee replacement |
Conversion from hybrid total prosthetic hip replacement NEC |
Conversion from hybrid total prosthetic hip replacement (procedure) |
Conversion from hybrid total prosthetic hip replacement NEC |
Conversion from hybrid total prosthetic hip replacement (procedure) |
Conversion from other type of arthroplasty |
Operation on joint arthroplasty (procedure) |
Conversion from previous arthrodesis NEC |
Revision of arthrodesis |
Conversion from previous hemiarthroplasty of hip NEC |
Revision of hip arthroplasty |
Conversion from previous total prosthetic replacement of hip joint NEC |
Conversion from total prosthetic replacement of hip joint (procedure) |
Conversion to arthrodesis NEC |
Revision of arthrodesis |
Conversion to arthrodesis NOS |
Revision of arthrodesis |
Conversion to total prosthetic replacement of hip joint NEC |
Conversion to total prosthetic replacement of hip joint (procedure) |
Cook NOS |
Cook |
Cook NOS |
Cook |
Coombs test NOS |
Coombs test - anti-human globulin |
Coombs test NOS |
Coombs test - anti-human globulin |
Copper supplement |
Product containing copper (medicinal product) |
Cord tangled with compression unspecified |
Entanglement and compression of umbilical cord (disorder) |
Cord tangled with compression with antenatal problem |
Entanglement and compression of umbilical cord (disorder) |
Cordylobia |
Cordylobia anthropophaga |
Cormack and Lehane score |
Cormack and Lehane system (assessment scale) |
Corn oil - dietary |
Corn oil (substance) |
Cornea guttata |
Corneal guttata |
Corneal anesthesia |
Corneal anesthesia (finding) |
Corneal endotheliolitis |
Corneal endotheliitis |
Corneal epithelial and basement membrane dystrophy |
Epithelial basement membrane dystrophy (disorder) |
Corneal fragility keratoglobus, blue sclerae AND joint hypermobility |
A rare, hereditary connective tissue disease characterized by severe ocular manifestations due to extreme corneal thinning and fragility with rupture in the absence of significant trauma, often leading to irreversible blindness. Extraocular manifestations comprise deafness, developmental hip dysplasia, and joint hypermobility. |
Coronary A by-pass anastam NOS |
Coronary artery bypass graft |
Coronary A by-pass anastam NOS |
Coronary artery bypass graft |
Coronary arteriog-general NOS |
Angiography of coronary artery (procedure) |
Coronary arteriog-general NOS |
Angiography of coronary artery (procedure) |
Coronary artery dissection |
Dissection of coronary artery (disorder) |
Coronary artery operations NOS |
Operative procedure on coronary artery (procedure) |
Coronary artery operations NOS |
Operative procedure on coronary artery (procedure) |
Coronary heart disease risk clinical management plan |
Coronary heart disease risk clinical management plan |
Coronary orifice atresia |
Congenital atresia of coronary ostium |
Coronary vasodilator |
Vasodilator (substance) |
Coronavirus |
Subfamily Orthocoronavirinae (organism) |
Coronavirus as the cause of diseases classified to other chapters |
Coronavirus infection |
Coronavirus as the cause of diseases classified to other chapters |
Coronavirus infection |
Corpus luteum of pregnancy |
Corpus luteum of pregnancy |
Corpus uteri TNM finding |
American Joint Committee on Cancer allowable value |
Correction by appliance |
Appliance procedures |
Correction by appliance |
Appliance procedures |
Correction by appliance NOS |
Appliance procedures |
Correction by appliance NOS |
Appliance procedures |
Correction of atresia of external meatus of ear |
Meatoplasty of external ear |
Correction of displacement of prosthesis NOC |
Attention to device (procedure) |
Correction of tricuspid atresia |
Repair of tricuspid atresia |
Corsodyl original mouthwash |
Product manufactured as oromucosal dose form (product) |
Cortex contusion with open intracranial wound and unspecified state of consciousness |
Cortex contusion with open intracranial wound |
Cortex contusion with open intracranial wound, with concussion, unspecified |
Contusion of cerebrum with open intracranial wound |
Cortex contusion with open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of cerebrum with open intracranial wound |
Cortex contusion without mention of intracranial wound, with 1-24 hours loss of consciousness |
Contusion of cerebral cortex |
Cortex contusion without mention of open intracranial wound, with less than 1 hour loss of consciousness |
Contusion of cerebral cortex |
Cortex contusion without mention of open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of cerebral cortex |
Cortex contusion without mention of open intracranial wound, with more than 24 hours loss of consciousness and return to pre-existing conscious level |
Contusion of cerebral cortex |
Cortex contusion without mention of open intracranial wound, with more than 24 hours loss of consciousness without return to pre-existing conscious level |
Contusion of cerebral cortex |
Cortex contusion without mention of open intracranial wound, with no loss of consciousness |
Contusion of cerebral cortex |
Cortex contusion without mention of open intracranial wound, with unspecified state of consciousness |
Contusion of cerebral cortex |
Cortex contusion without open intracranial wound |
Contusion of cerebral cortex |
Cortex contusion without open intracranial wound AND with concussion |
Contusion of cerebral cortex |
Cortex contusion without open intracranial wound AND with loss of consciousness |
Contusion of cerebral cortex |
Cortex contusion without open intracranial wound and with unspecified state of consciousness |
Contusion of cerebral cortex |
Cortex laceration with open intracranial wound and unspecified state of consciousness |
Cortex laceration with open intracranial wound |
Cortical dysplasia with focal epilepsy syndrome |
A rare genetic syndromic neurodevelopmental disorder with characteristics of moderate to mostly severe intellectual disability, speech impairment with normal or mildly delayed motor development and early-onset seizures often accompanied by developmental regression. Autistic behaviour and stereotypic movements are common. The disorder is caused by bi-allelic intragenic deletions (rarely duplications) or truncating variants in the CNTNAP2 gene (7q35-q36.1). It encodes contactin-associated protein 2 (CASPR2), a transmembrane protein from the neurexin superfamily, which is involved in neural-glia interactions and clustering of potassium channels in myelinated axons. Inheritance is autosomal recessive. |
Corticosteroid binding globulin |
Corticotropin binding globulin |
Corynebacterium flaccumfaciens |
Curtobacterium flaccumfaciens |
Corynebacterium flaccumfaciens subsp betae |
Curtobacterium flaccumfaciens |
Corynebacterium flaccumfaciens subsp oortii |
Curtobacterium flaccumfaciens |
Corynebacterium flaccumfaciens subsp poinsettiae |
Curtobacterium flaccumfaciens |
Corynebacterium liquefaciens |
Brevibacterium liquefaciens |
Corynebacterium nigricans |
Corynebacterium aurimucosum (organism) |
Corynebacterium paurometabolum |
Tsukamurella paurometabola (organism) |
Corynebacterium vitarumen |
Corynebacterium vitaeruminis (organism) |
Costing/accounting clerk NOS |
Costing/accounting clerk |
Costing/accounting clerk NOS |
Costing/accounting clerk |
Cough suppressants |
Antitussive agent (substance) |
Counseled by person NOS |
Person counselled by |
Counseling - general NOS |
Counseling procedure with explicit context (situation) |
Counseling by other agency |
Person counselled by |
Counseling for grieving NOS |
Grieving counselling |
Counselled by person NOS |
Person counselled by |
Counselling - general NOS |
Psychosocial procedure that involves listening, reflecting, etc. to facilitate recognition of course of action / solution. |
Counselling by other agency |
Person counselled by |
Count of active ingredient |
This attribute represents the number of active ingredients or precise active ingredients in a medicinal product. It is simply a count of attribute 'has active ingredient' or 'has precise active ingredient' in a concept definition. |
Count of base and modification pair |
This attribute represents the number of different base and modification pairs in a medicinal product. If both bases and their modifications are the same, it is counted as 1 pair. The count is increased when the bases are the same but their modifications are different, for two or more pairs. Any further modification should not be counted as part of the pair. |